| |
| |
|
| Insider
Information: |
Goldstein Joseph L |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,382 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,118,040 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,382 |
|
|
| Total
Value |
$6,118,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 10.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-23 |
6,382 |
2003-10-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-23 |
4 |
AS |
$950.00 |
$2,571,650 |
D/D |
(2,707) |
6,382 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-23 |
4 |
OE |
$625.60 |
$1,693,499 |
D/D |
2,707 |
9,089 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
6,382 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-06 |
4 |
AS |
$800.00 |
$2,890,400 |
D/D |
(3,613) |
6,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-06 |
4 |
OE |
$482.68 |
$1,743,923 |
D/D |
3,613 |
9,860 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
165 |
6,247 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-30 |
4 |
AS |
$700.00 |
$1,701,700 |
D/D |
(2,431) |
6,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-30 |
4 |
OE |
$374.12 |
$909,486 |
D/D |
2,431 |
8,513 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
191 |
6,082 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-09-10 |
4 |
AS |
$650.00 |
$1,611,350 |
D/D |
(2,479) |
5,891 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-09-10 |
4 |
OE |
$380.95 |
$944,375 |
D/D |
2,479 |
8,370 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-06-07 |
4 |
AS |
$525.00 |
$1,013,250 |
D/D |
(1,930) |
5,891 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-06-07 |
4 |
OE |
$374.12 |
$722,052 |
D/D |
1,930 |
7,821 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
5,891 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-10-05 |
4 |
AS |
$600.00 |
$5,527,200 |
D/D |
(9,212) |
5,643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-10-05 |
4 |
OE |
$520.01 |
$4,790,332 |
D/D |
9,212 |
14,855 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-09-22 |
4 |
AS |
$552.36 |
$11,047 |
D/D |
(20) |
5,643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-09-21 |
4 |
AS |
$543.19 |
$9,102,446 |
D/D |
(16,554) |
5,663 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-09-21 |
4 |
OE |
$371.40 |
$6,244,372 |
D/D |
16,574 |
22,217 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-21 |
4 |
S |
$617.18 |
$617,180 |
D/D |
(1,000) |
5,643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-06-08 |
4 |
OE |
$413.33 |
$4,479,671 |
D/D |
10,838 |
17,481 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-06-08 |
4 |
AS |
$580.65 |
$6,426,362 |
D/D |
(10,838) |
6,643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-28 |
4 |
S |
$578.94 |
$578,940 |
D/D |
(1,000) |
6,643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-06 |
4 |
S |
$560.00 |
$1,120,000 |
D/D |
(2,000) |
7,643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-03-09 |
4 |
AS |
$468.14 |
$951,684 |
D/D |
(2,000) |
9,643 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
